...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Membrane binding and insertion of the predicted transmembrane domain of human scramblase 1
【24h】

Membrane binding and insertion of the predicted transmembrane domain of human scramblase 1

机译:膜结合和插入人血管癌的预测跨膜结构域1

获取原文
获取原文并翻译 | 示例

摘要

Human phospholipid scramblase I (SCR) was originally described as an intrinsic membrane protein catalyzing transbilayer phospholipid transfer in the absence of ATP. More recently, a role as a nuclear transcription factor has been proposed for SCR, either in addition or alternatively to its capacity to facilitate phospholipid flip-flop. Uncertainties exist as well from the structural point of view. A predicted a-helix (aa residues 288-306) located near the C-terminus has been alternatively proposed as a transmembrane domain, or as a protein core structural element. This paper explores the possibilities of the above helical segment as a transmembrane domain. To this aim two peptides were synthesized, one corresponding to the 19 a-helical residues, and one containing both the helix and the subsequent 12-residues constituting the C-end of the protein. The interaction of these peptides with lipid monolayers and bilayers was tested with Langmuir balance surface pressure measurements, proteoliposome reconstitution and analysis, differential scanning calorimetry, tests of bilayer permeability, and fluorescence confocal microscopy. Bilayers of 28 different lipid compositions were examined in which lipid electric charge, bilayer fluidity and lateral heterogeneity (domain formation) were varied. All the results concur in supporting the idea that the 288-306 peptide of SCR becomes membrane inserted in the presence of lipid bilayers. Thus, the data are in agreement with the possibility of SCR as an integral membrane protein, without rejecting alternative cell locations. (C) 2013 Elsevier B.V. All rights reserved.
机译:人磷脂曲酶I(SCR)最初被描述为在没有ATP的情况下催化转段磷脂转移的内在膜蛋白。最近,已经提出了作为核转录因子的作用,用于SCR,或者可以替代地促进其促进磷脂触发器的能力。不确定性也存在于结构的结构点。替代地提出了位于C-末端附近的预测的A-Helix(AA残基288-306)作为跨膜结构域,或作为蛋白质核心结构元件。本文探讨了上述螺旋段作为跨膜结构域的可能性。为了该目的,合成了两种肽,对应于19A螺旋残留物,一种含有螺旋和随后的12-残基构成蛋白质的C末端。用Langmuir平衡表面压力测量,蛋白质体重构和分析,差示扫描量热法,双层渗透性试验和荧光共聚焦显微镜测试这些肽与脂质单层和双层的相互作用。检查了28种不同脂质组合物的双层,其中改变了脂质电荷,双层流动性和横向异质性(结构域形成)。所有结果都同意支持SCR 288-306肽在脂质双层存在下插入的膜。因此,数据与SCR作为整体膜蛋白的可能性一致,而不会拒绝替代细胞位置。 (c)2013年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号